| Similar Articles |
|---|
 |
Chemistry World
June 20, 2013
Sarah Houlton |
US supreme court rules genes can't be patented In a long-running case against Myriad Genetics, the court decided the BRCA1 and BRCA2 genes are a 'product of nature, and not patent eligible merely because [they have] been isolated.'   |
The Motley Fool
March 31, 2010
Brian Orelli |
When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies. |
The Motley Fool
July 1, 2011
Dan Radovsky |
Can the Human Genetics Industry Survive the Courts? The future of gene patents is at stake. |
Salon.com
April 24, 2000
Mark Compton |
Lean, green gene-counting machine Incyte CEO Roy Whitfield gives biotech investors and patent critics a few lessons on genomic research. |
The Motley Fool
February 2, 2010
Brian Orelli |
Shaking Up the Biotech Industry A judge will decide if genes are patentable or not. |
Bio-IT World
November 12, 2002
Paula Campbell Evans |
Patently More Difficult The PTO has targeted gene patents with new application guidelines. Here's what they mean and how biotech companies can satisfy them. |
Chemistry World
January 7, 2015
Rebecca Trager |
Myriad loses appeal on cancer gene test patents Myriad Genetics has lost its appeal over patents on the BRCA genes that are associated with a higher risk of breast and ovarian cancer. |
Bio-IT World
November 2005
Khaleeli & Fernandez |
Patent Prosecution and Enforcement in Pharmacogenomics Patenting the composition of an isolated nucleic acid sequence, an isolated protein, and small molecules is possible, but there are challenges claiming that they resulted from pharmacogenomic research. |
Bio-IT World
November 12, 2002
Andrew W. Torrance |
After the Gene Rush About 20,000 gene-related patents have been granted in the U.S. so far, with twice as many on the way. The practical and political challenges are equally large. |
Bio-IT World
August 13, 2003
Kevin Davies |
Malcolm in the Middle A maverick scientist and entrepreneur finds himself at the center of a DNA patenting storm. |
Bio-IT World
August 13, 2003
Kevin Davies |
Playing by Aussie Rules GTG's Mervyn Jacobson discusses the controversial patenting of non-coding DNA. |
Bio-IT World
November 12, 2002
Beth E. Arnold |
Navigating Gene Patent Minefields As the number of gene-related patents soars, so do the chances of patent infringement. Here are tips to avoid a costly misstep in this legal minefield. |
| Knowledge@Wharton |
Why High-Tech Firms Can't Afford to Ignore Patents When it comes to patents, high technology firms are, out of necessity, interdependent... |
Salon.com
May 1, 2000
Arthur Allen |
Listening to DNA The genome project is getting the buzz. But the real breakthroughs may come from labs out of the limelight, like Gene Logic. |
Chemistry World
January 30, 2015
Rebecca Trager |
Myriad calls a ceasefire in court battle over cancer gene tests Myriad Genetics has ended its bid to prevent other companies from producing tests for genetic mutations associated with an increased risk of breast and ovarian cancer that it owned patents on. |
Pharmaceutical Executive
September 1, 2010 |
Looking Beyond the Patent Cliff Pfizer's VP and Assistant General Counsel for Global Patents and Policy, Roy Waldron, discusses its collaborative strategy to refresh the face of IP. |
InternetNews
November 24, 2004
Jim Wagner |
Nick Godici, Commissioner for Patents, USPTO The U.S. Patent & Trademark Office has been taking a lot of heat in recent years over software patents. Sitting at the center of the firestorm, and the patent process, is Nick Godici, the agency's Commissioner for Patents. |
Chemistry World
March 23, 2012
Rebecca Trager |
Court throws out patent covering drug dosing The US Supreme Court has said that medical tests that rely on correlations between drug doses and treatment cannot be patented because they are based on laws of nature. |
Chemistry World
October 2006 |
Head to Head For: Patents protect inventions by giving the owner of the patent the right to stop anyone from making or using the invention without the owner's permission... Against: Patents are a menace... |
ONLINE
Nov/Dec 2008
Suzanne Sabroski |
From Concept to Content: The Genesis of USGENE Last year a groundbreaking database known as USGENE was released on STN International, a service of FIZ Karlsruhe and Chemical Abstracts Service (CAS). USGENE allows searchers to perform freedom-to-operate, prior art, validity, and infringement patent sequence searches. |
Reason
August 2002
Charles Paul Freund |
DNA Dough-Re-Mi A pretty girl may be like a melody, but the music of her DNA could have biotech companies whistling all the way to the bank. An executive at Maxygen, a California biotech firm, has suggested that if DNA sequences were converted to digital music they could be copyrighted as works of art. |
Inc.
July 24, 2002
Jennifer A. Redmond |
Strategic Patenting What to consider when you're filing a patent and strategic decisions you'll need to make. |
IEEE Spectrum
August 2005
Ben Klemens |
New Legal Code Copyrights should replace software patents. |
InternetNews
May 20, 2005
Sean Michael Kerner |
A Primer on Software Patents A closer look at software patents and at their history and implications for IT. |
HHMI Bulletin
Aug 2010
Sarah C.P. Williams |
Switching Plants' Reproductive Methods The shipments of seeds that farms rely on at the beginning of each growing season could soon be a relic of the past. Scientists have discovered how to coax plants to clone themselves by altering their reproductive methods. |
Fast Company
November 2009
David H. Freedman |
The Gene Bubble: Why We Still Aren't Disease-Free When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens. |
Information Today
April 2005
George H. Pike |
Patenting the Internet The role of Internet patents has come into question as a number of patents have been issued to cover routine Internet practice such as media streaming. |
Entrepreneur
October 2005
Chris Penttila |
Patent Pending Have an idea for the next big thing? You'll need a patent, but pay attention to big changes in store for U.S. patent law. |
BusinessWeek
June 13, 2005
John Carey |
The NIH's Roadmap for Research Charting the human genome was just the beginning. Now the focus is creating pathways that will lead to practical applications. |
Salon.com
December 19, 2000
Carolyn McConnell |
"The Century of the Gene" by Evelyn Fox Keller A new book argues that there may be no such thing as a gene. At least, it has proved very difficult to isolate a discrete physical item that can do the work our notion of the gene does... |
CIO
January 1, 2003
Christopher Koch |
Patently Stupid? It's not clear at the start of 2003 whether the software patent frenzy will cause innovation to flower or be trampled. |
American Family Physician
October 1, 2000 |
Genetic Testing for Breast Cancer Risk: What Does It Mean to Me? What causes breast cancer?... What genes can cause breast cancer to be inherited?... What clues in my family history might show I've inherited a risk of breast cancer?... Does everyone who has family members with breast cancer have these mutated genes?... What should I do?... |
Chemistry World
April 2, 2015
Jenny Lovell |
DNA test colors in BRCA1 gene Researchers in China have developed an ultrasensitive test that changes color when it detects a gene associated with an increased risk of developing breast and ovarian cancer. |
BusinessWeek
January 13, 2010
Steve LeVine |
IBM May Not Be the Patent King After All IBM wins more U.S. patents than any other company, but Microsoft's are worth much more money, says a new study. |
IEEE Spectrum
February 2006
Lee A. Hollaar |
Patents 2.0 There are big problems with patents, especially software patents. A new type of patent is needed -- Congress should create a new, limited protection that protects against knockoffs without overreaching. |
IndustryWeek
October 1, 2007
Jill Jusko |
Patent Protection Your valuable intellectual property requires keen oversight. To help keep it safe, consider these actions. |
Pharmaceutical Executive
May 1, 2005
Margaret Buck |
Legal: No Exception? An important legal loophole has made patented tools available for biotech research. Today, though, it appears to be closing. |
IEEE Spectrum
March 2009
Steven J. Frank |
The Death of Business-Method Patents From now on, you can get a U.S. patent only on a mousetrap -- not on the idea of catching mice |
Pharmaceutical Executive
September 1, 2012
Roy F. Waldron |
Open Innovation in Pharma: Defining the Dialogue There is much talk today about "open innovation" in business and research forums, but what exactly does it mean? How does open innovation as a concept apply to the pharmaceutical sector? |
Reason
April 2007
Ronald Bailey |
Testing Your Strength The World Anti-Doping Agency is developing tests for a form of cheating that doesn't exist yet. The agency banned gene doping, the alteration of genes to enhance athletic performance. |
Pharmaceutical Executive
April 1, 2012
William Looney |
IP: Time for a Reset? Patents are the chief incentive for drug development. Industry should educate stakeholders about IP protection as a crucial driver of innovation, before it's too late. |
InternetNews
January 11, 2005
Jim Wagner |
IBM Pledges Patents to Open Source IBM said Tuesday it is pledging 500 software patents to developers of open source software so they can develop without fear. The patents are available to those who abide by the Open Source Initiative (OSI) and use one of 50 OSI-certified licenses. |
Chemistry World
December 8, 2011
Sarah Houlton |
Academia Grows Its Role in Drug Discovery The number of pharma patents being filed by universities around the world is soaring compared with those coming from industry. |
CIO
September 28, 2012
Kim S. Nash |
Companies Race to the Patent Office to Protect Their IT Breakthroughs There's a patent gold rush under way as savvy companies seek to lock in the competitive advantage from their IT innovations. CIOs ought to seek patents for unique business methods and other inventions made possible by new technology. |
Chemistry World
June 4, 2009
Sarah Houlton |
Agrochemical firms in patent battle BASF and DuPont are squaring up for a battle over technology that makes plants resistant to commonly used herbicides. |
InternetNews
October 21, 2004
Sean Michael Kerner |
EU Patent Fight Comes to the Fore An effort to stop software patents in the European Union got a boost this week with the launch of NoSoftwarePatents.com. Red Hat and MySQL AB are among the high-profile open source companies backing the effort. |
InternetNews
March 16, 2004
Susan Kuchinskas |
Patently Unfair? Overworked patent examiners and outdated rules are just two of the reasons critics of some tech patents say the process needs fixing. |
Reason
Aug/Sep 2000
Ronald Bailey |
Strands of Life Book Review: Genome: The Autobiography of a Species in 23 Chapters, by Matt Ridley |
InternetNews
November 10, 2005
Clint Boulton |
New Company Launched to Spread Linux IBM, Novell, Philips, Red Hat and Sony form the Open Invention Network to acquire patents and offer them royalty-free in order to extend open source operating systems worldwide. |
Information Today
May 2004
George H. Pike |
You Can't Do That, It's Patented There are an increasing number of questionable patent claims that cover Internet technologies and techniques, and permission must be obtained for their use. |
